HLA-G in cancer: a way to turn off the immune system
- 19 September 2003
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 13 (5) , 325-336
- https://doi.org/10.1016/s1044-579x(03)00023-3
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Selective expression of HLA‐G in malignant and premalignant skin specimens in kidney transplant recipientsInternational Journal of Cancer, 2003
- Major histocompatibility complex abnormalities in non‐Hodgkin lymphomasBritish Journal of Haematology, 2002
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-? immunotherapyCancer, 2001
- Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanomaThe Lancet, 2000
- Melanomas and melanoma cell lines do not express HLA‐G, and the expression cannot be induced by γIFN treatmentTissue Antigens, 2000
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- HLA-G revisitedImmunology Today, 1996
- Invasion of the trophoblastsCell, 1992